Panel: Reimagining DTC Advertising Amid Regulatory Change and Consumer Demand

Session details:

• Explore how increased FDA scrutiny is reshaping DTC strategy and why being proactive (not reactive) is key to maintaining momentum and avoiding regulatory setbacks
• Understand how brands are evolving DTC messaging to balance compliance, education, and authenticity, even as disclaimers grow longer and patient skepticism rises
• Learn how to responsibly use digital and social channels to meet patient expectations, navigate regulatory gray areas, and maintain engagement in a more regulated environment
• Examine how marketers are rethinking budget allocation between HCP and DTC efforts to sustain growth while adapting to changing regulatory and market dynamics
• Discover how global perspectives on DTC and lessons from markets where it isn't allowed are influencing U.S. strategy, creativity, and long-term planning